Joshua Lev Sells 2,500 Shares of electroCore (NASDAQ:ECOR) Stock

electroCore, Inc. (NASDAQ:ECOR) CFO Joshua Lev sold 2,500 shares of the stock in a transaction dated Thursday, December 4th. The stock was sold at an average price of $5.05, for a total transaction of $12,625.00. Following the transaction, the chief financial officer directly owned 21,667 shares of the company’s stock, valued at approximately $109,418.35. This trade represents a 10.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

electroCore Stock Performance

Shares of electroCore stock traded down $0.13 on Friday, reaching $4.82. The company had a trading volume of 9,759 shares, compared to its average volume of 107,759. The firm’s 50 day moving average price is $5.10 and its two-hundred day moving average price is $5.46. electroCore, Inc. has a 52-week low of $4.16 and a 52-week high of $19.49. The firm has a market cap of $38.56 million, a PE ratio of -2.82 and a beta of 0.33.

electroCore (NASDAQ:ECOR) last posted its quarterly earnings data on Wednesday, November 5th. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.07). The company had revenue of $8.69 million for the quarter, compared to analysts’ expectations of $7.84 million. electroCore had a negative return on equity of 447.87% and a negative net margin of 47.46%. As a group, sell-side analysts predict that electroCore, Inc. will post -1.49 EPS for the current year.

Hedge Funds Weigh In On electroCore

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. XTX Topco Ltd acquired a new position in shares of electroCore during the first quarter worth about $90,000. Jump Financial LLC acquired a new position in electroCore during the 1st quarter worth approximately $95,000. Two Sigma Investments LP increased its position in shares of electroCore by 20.8% in the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock valued at $122,000 after purchasing an additional 4,231 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new stake in shares of electroCore in the 1st quarter valued at approximately $153,000. Finally, Jaffetilchin Investment Partners LLC raised its holdings in shares of electroCore by 26.7% in the 2nd quarter. Jaffetilchin Investment Partners LLC now owns 41,783 shares of the company’s stock valued at $221,000 after purchasing an additional 8,800 shares in the last quarter. Hedge funds and other institutional investors own 26.74% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on ECOR. Wall Street Zen raised electroCore from a “sell” rating to a “hold” rating in a research note on Saturday, November 8th. Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a report on Monday. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $25.50.

electroCore Company Profile

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.